Bodymed

Bodymed is a specialized healthcare company focused on medically supervised weight management and metabolic health programs. Based in Germany, the company developed the Bodymed Nutrition Concept, which utilizes meal replacement products and nutritional counseling to address obesity and related metabolic disorders. A key component of their portfolio is the Hepafast program, designed specifically to reduce liver fat and improve insulin sensitivity in patients with non-alcoholic fatty liver disease. The company operates through a network of over 1,350 centers across the DACH region, providing evidence-based nutritional solutions. In 2020, Bodymed was acquired by Nestlé Health Science, integrating its clinical nutrition expertise into Nestlé's global health science portfolio.